WallStSmart

Arthur J Gallagher & Co (AJG)vsCorVel Corp (CRVL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Arthur J Gallagher & Co generates 1282% more annual revenue ($13.01B vs $941.49M). AJG leads profitability with a 11.5% profit margin vs 11.2%. CRVL trades at a lower P/E of 25.6x. AJG earns a higher WallStSmart Score of 60/100 (C).

AJG

Buy

60

out of 100

Grade: C

Growth: 6.7Profit: 5.0Value: 7.3Quality: 4.3
Piotroski: 4/9Altman Z: 0.76

CRVL

Hold

45

out of 100

Grade: D+

Growth: 5.3Profit: 7.5Value: 5.7Quality: 8.0
Piotroski: 5/9Altman Z: 5.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AJGSignificantly Overvalued (-426.0%)

Margin of Safety

-426.0%

Fair Value

$39.03

Current Price

$213.56

$174.53 premium

UndervaluedFair: $39.03Overvalued
CRVLSignificantly Overvalued (-121.1%)

Margin of Safety

-121.1%

Fair Value

$21.05

Current Price

$52.25

$31.20 premium

UndervaluedFair: $21.05Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AJG4 strengths · Avg: 8.8/10
Revenue GrowthGrowth
36.7%10/10

Revenue surging 36.7% year-over-year

Market CapQuality
$54.91B9/10

Large-cap with strong market position

PEG RatioValuation
0.938/10

Growing faster than its price suggests

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

CRVL3 strengths · Avg: 9.7/10
Return on EquityProfitability
31.3%10/10

Every $100 of equity generates 31 in profit

Altman Z-ScoreHealth
5.9510/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.129/10

Conservative balance sheet, low leverage

Areas to Watch

AJG4 concerns · Avg: 2.8/10
P/E RatioValuation
37.2x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
6.9%3/10

ROE of 6.9% — below average capital efficiency

EPS GrowthGrowth
-48.3%2/10

Earnings declined 48.3%

Altman Z-ScoreHealth
0.762/10

Distress zone — elevated risk

CRVL3 concerns · Avg: 4.0/10
P/E RatioValuation
25.6x4/10

Moderate valuation

Revenue GrowthGrowth
3.4%4/10

3.4% revenue growth

EPS GrowthGrowth
2.2%4/10

2.2% earnings growth

Comparative Analysis Report

WallStSmart Research

Bull Case : AJG

The strongest argument for AJG centers on Revenue Growth, Market Cap, PEG Ratio. Revenue growth of 36.7% demonstrates continued momentum. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bull Case : CRVL

The strongest argument for CRVL centers on Return on Equity, Altman Z-Score, Debt/Equity.

Bear Case : AJG

The primary concerns for AJG are P/E Ratio, Return on Equity, EPS Growth.

Bear Case : CRVL

The primary concerns for CRVL are P/E Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

AJG profiles as a growth stock while CRVL is a value play — different risk/reward profiles.

CRVL carries more volatility with a beta of 1.11 — expect wider price swings.

AJG is growing revenue faster at 36.7% — sustainability is the question.

AJG generates stronger free cash flow (713M), providing more financial flexibility.

Bottom Line

AJG scores higher overall (60/100 vs 45/100) and 36.7% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arthur J Gallagher & Co

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Arthur J. Gallagher & Co. (AJG) is an American global insurance brokerage and risk management services firm headquartered in Rolling Meadows, Illinois.

CorVel Corp

FINANCIAL SERVICES · INSURANCE BROKERS · USA

CorVel Corporation provides workers' compensation, auto, liability and health solutions for employers, outside administrators, insurance companies, and government agencies to help them manage medical costs and monitor the quality of care associated with health care claims. The company is headquartered in Fort Worth, Texas.

Visit Website →

Want to dig deeper into these stocks?